Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Global RNA Analysis Market Research Report 2021 - ResearchAndMarkets.com


The "Global RNA Analysis Market 2021-2026" report has been added to ResearchAndMarkets.com's offering.

This study offers a global view of RNA analysis for various applications. This report analyzes and assesses different types of RNA analysis involved, namely microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing. It also provides information by application, categorized as clinical diagnosis, drug discovery and toxicogenomics.

RNA analysis can reveal diseases and systems that contribute to death, and this type of analysis can be a useful tool in forensic pathology for determining the cause of death. RNA species (messenger RNA, transfer RNA, and ribosomal RNA) play an important role in the translation of genetic information from DNA to proteins.

MicroRNA and other short, non-coding RNAs have lately been discovered to have new functions in gene regulation. From large-scale analyses of the transcriptome - the whole collection of RNA transcripts encoded by a genome - to exploring the actions of individual short, non-coding RNAs on specific genes, RNA analysis research encompasses a wide range of issues.

For gene expression analysis, RT-qPCR is a must-have tool. During an experiment, RT-qPCR devices are used to detect and monitor the expression of specific RNA targets in real-time.

RNases (RNA-degrading enzymes) are ubiquitous. It is crucial to successfully isolate RNA and keep it intact, especially when delicate downstream applications are involved (e.g., RNA sequencing). All RNA purification and handling should take place in a lab that is RNase-free and RNA-only, and gloves should be used at all times to avoid contamination. Using an RNase inhibitor to protect samples from RNase degradation is crucial.

This report explores the present and future market values of the RNA analysis market, particularly by type of analysis such as microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing. Market analysis for applications such as clinical diagnosis, drug discovery and toxicogenomics is also explored in the report.

Also included in the report is a discussion of the impact of COVID-19 on the market and profiles of leading companies in the RNA analysis market. The leading firms in the market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, CD Genomics, Promega Corp., Illumina Inc., Qiagen NV, Danaher Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, Fluidigm Corp., and Eurofins Scientific.

The Report Includes

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Overview

Chapter 4 Global Market for RNA Analysis/Transcriptomics

Chapter 5 Drivers and Challenges

Chapter 6 Supplier Landscape, Company Share Analysis and Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/mvggbh


These press releases may also interest you

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: